Oppenheimer Asset Management Inc. Trims Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Oppenheimer Asset Management Inc. lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 87,846 shares of the healthcare conglomerate’s stock after selling 1,961 shares during the period. UnitedHealth Group accounts for approximately 0.6% of Oppenheimer Asset Management Inc.’s portfolio, making the stock its 26th largest holding. Oppenheimer Asset Management Inc.’s holdings in UnitedHealth Group were worth $51,362,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in UNH. Kathleen S. Wright Associates Inc. bought a new position in UnitedHealth Group in the 3rd quarter valued at $27,000. Global Wealth Strategies & Associates boosted its stake in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 32 shares during the period. Macroview Investment Management LLC increased its stake in UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after acquiring an additional 47 shares during the last quarter. West Financial Advisors LLC bought a new stake in shares of UnitedHealth Group during the 3rd quarter valued at about $32,000. Finally, Delos Wealth Advisors LLC increased its position in shares of UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 53 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

UNH has been the topic of several research reports. Bank of America lowered their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Cantor Fitzgerald lifted their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 16th. Truist Financial reiterated a “buy” rating and issued a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. HSBC downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. Finally, Stephens reduced their price target on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. Three investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Stock Down 0.4 %

NYSE:UNH traded down $2.62 on Wednesday, reaching $612.05. 333,604 shares of the stock traded hands, compared to its average volume of 3,880,817. The company’s fifty day simple moving average is $582.95 and its 200 day simple moving average is $547.62. The company has a market capitalization of $563.26 billion, a price-to-earnings ratio of 40.07, a PEG ratio of 1.84 and a beta of 0.58. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. During the same period last year, the business posted $6.56 EPS. The company’s revenue was up 9.2% compared to the same quarter last year. Equities analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.37%. UnitedHealth Group’s payout ratio is 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.